EQS-News: Marinomed Biotech AG / Key word: Market Launch
Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico.
EQS-News: Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
EQS-News: Marinomed Biotech AG / Key word(s): Market LaunchMarinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico 11.04.2024 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement.Marinomed Biotech AG: Launch of new allergen-bloc.
EQS-News: Marinomed Biotech AG / Key word(s): AgreementMarinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months 28.03.2024 / 07:45 CET/CESTThe issuer is solely responsible for the content of this announcement. Marinomed Biotech AG an.